NEW YORK, June 4 - DNA Link of Seoul, South Korea, has agreed to buy Orchid’s SNPstream 25K SNP-scoring system, the companies said.
"We acquired Orchid’s SNPstream 25K automated genotyping solution to enable us to accelerate our varied programs in medical genetics," Jong Eun Lee, co-CEO of DNA Link, said recently in a statement.
“We expect that the SNPstream system’s mix of accuracy, robustness, and cost effectiveness combined with access to Orchid’s growing SNP databases will contribute to the rapid progress of our gene discovery and pharmacogenetics programs,” he said.
DNA Link, a medical genetics research company, is Orchid’s first customer in Asia to buy the SNPstream system, which can analyze up to 25,000 SNPs per day.
Financial terms of the agreement were not disclosed.
In addition to the SNPstream system, Orchid BioSciences of Princeton, NJ, also offers SNP scoring and pharmacogenetic testing services.